About Strand Life Sciences
Strand Life Sciences is a company based in Bengaluru (India) founded in 2000 by Vinay V, Ramesh Hariharan, and Vijay Chandru was acquired by Reliance Industries in September 2021. Strand Life Sciences has raised $34.88 million across 9 funding rounds from investors including HCG, Syngene and WestBridge Capital. The company has 428 employees as of March 29, 2024. Strand Life Sciences operates in a competitive market with competitors including deCODE Genetics, Hexagon Bio, ONCOHOST, Cellanome and Allelica, among others.
- Headquarter Bengaluru, India
- Employees 428 as on 29 Mar, 2024
- Founders Vinay V, Ramesh Hariharan, Vijay Chandru
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Strand Life Sciences Private Limited
- Date of Incorporation 06 Oct, 2000
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$10.55 M (USD)-14.65as on Mar 31, 2023
-
Net Profit
$1.65 M (USD)-77.06as on Mar 31, 2023
-
EBITDA
$59.16 K (USD)-43.32as on Mar 31, 2023
-
Total Equity Funding
$34.88 M (USD)
in 9 rounds
-
Latest Funding Round
$13.84 M (USD), Series C
Feb 07, 2018
-
Investors
HCG
& 28 more
-
Employee Count
428
as on Mar 29, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Strand Life Sciences
Unlock access to complete
Funding Insights of Strand Life Sciences
Strand Life Sciences has successfully raised a total of $34.88M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $13.84 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Strand Life Sciences
Strand Life Sciences has secured backing from 29 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include HCG, Syngene and WestBridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Locked | Locked | Locked | |
|
Healthcare investment fund focused on innovation and social impact in India.
|
Locked | Locked | Locked | |
|
Private equity and venture capital investment firm
|
Locked | Locked | Locked |
Investor details for Strand Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Strand Life Sciences
Investment portfolio details for Strand Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Strand Life Sciences
Detailed financials for Strand Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Strand Life Sciences Comparisons
Peer comparison for Strand Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Strand Life Sciences
Strand Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as deCODE Genetics, Hexagon Bio, ONCOHOST, Cellanome and Allelica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bioinformatics platform for genetic disease analysis is provided.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
AI-based proteomic analysis for oncology therapy planning is offered.
|
|
| Locked | Locked | Locked |
Developer of the omic data platform for researchers
|
|
| Locked | Locked | Locked |
Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition
|
Detailed competitors of Strand Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Strand Life Sciences
Complete news archive for Strand Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strand Life Sciences
Strand Life Sciences was founded in 2000.
Strand Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Ramesh Hariharan is the current CEO of Strand Life Sciences. They have also founded this company.
Strand Life Sciences is a funded company, having raised a total of $34.88M across 9 funding rounds to date.
As of Mar 29, 2024, the latest employee count at Strand Life Sciences is 428.
Annual revenue of Strand Life Sciences is $10.55M as on Mar 31, 2023.
Strand Life Sciences was founded in 2000 in Bengaluru, India, within the biotechnology sector. Omics-based solutions are delivered for clinical genomics, systems biology, and drug discovery. Sequence-based diagnostics and clinical genomic data interpretation services are supplied to healthcare establishments. Integrated omics analysis, image management, systems biology modeling, and molecular modeling tools are also made available to support research and development operations.
Strand Life Sciences's top competitors include ONCOHOST, Hexagon Bio and Fios Genomics.
Strand Life Sciences has 29 investors. Key investors include HCG, Syngene, WestBridge Capital, Quadria Capital, and HealthQuad.
The valuation of Strand Life Sciences is $47.67M as of Feb 2018.